Plutux
$2.35
+12.98%
2026-09-03 16:00:01 EDT+$0.27
Financial Services
Asset Management
NASDAQ
Active Trading

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and ...

Price Action

$2.35
+12.98%+$0.27
High
Low
52W High-90.8%
Rel. vol
Interval
Range6.2h
VolumeSMA5SMA10
Solana Company, listed on NASDAQ under the symbol HSDT, is a medical device company headquartered in Newtown, Pennsylvania. Founded in 2014, the company focuses on developing innovative neurotechnology solutions to enhance neurological wellness. Its core strategy involves developing, licensing, and acquiring non-invasive platform technologies that harness the brain's intrinsic capacity ...Solana Company, listed on NASDAQ under the symbol HSDT, is a medical device company headquartered in Newtown, Pennsylvania. Founded in 2014, the company focuses on developing innovative neurotechnology solutions to enhance neurological wellness. Its core strategy involves developing, licensing, and acquiring non-invasive platform technologies that harness the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A flagship product is an investigational portable neuromodulation stimulator that delivers neurostimulation through the tongue. Clinical studies suggest that this approach significantly enhances the efficacy of physical exercises for individuals with neurological symptoms from conditions such as mild-to-moderate traumatic brain injury. Financially, Solana Company is a micro-cap with a market capitalization around $101.6 million. As of the latest TTM data, the company has 21 full-time employees. The company is led by CEO Dane Carl Andreeff. Key financial metrics indicate a high gross profit margin of 94.2%, but the company is currently unprofitable with a negative net profit margin of -1427.1%. The company has minimal debt and a strong current ratio of 9.9, indicating good short-term liquidity. The enterprise value is approximately $97.2 million, with an EV/Sales ratio of 10.1. The company is in the development stage, with significant research and development expenses relative to revenue (26.8% of revenue). Sales, general, and administrative expenses are also high, at 264.1% of revenue. Operating cash flow is negative, indicating that the company is using cash to fund operations. However, the company has a strong balance sheet with tangible asset value of $70.3 million and net current asset value of $25 million. Solana Company is part of the healthcare sector, specifically the medical devices industry. The company's website is solanacompany.co. As a publicly traded entity since June 2014, it is actively trading on the NASDAQ Capital Market. Despite recent rebranding to align with digital assets, as indicated in some sources, the core focus aligns with its description as a neurotechnology medical device firm. Key personnel include CEO Dane Carl Andreeff. The company's future success depends on regulatory approvals and successful commercialization of its investigational neurostimulation device.
Founded
2014
Employees
21
CEO
Dane Carl Andreeff
Full Name
Solana Company
Sector
Financial Services
Industry
Asset Management
ROE
-122.85%
Market Cap
$0.14B
Current Ratio
13.31
WACC
9.32%
ROIC
-510.33%

Contact Information

215 944 6100
642 Newtown Yardley Road, Newtown, PA 18940

Related stocksMedical - Devices

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026